San Diego—A new monitoring tool helps predict those patients on a general care floor who are at high risk for developing opioid-induced respiratory depression (OIRD).
Ashish Khanna, MD, FCCP, FCCM, an anesthesiologist, intensivist and associate professor of anesthesiology at Wake Forest School of Medicine, in Winston-Salem, N.C., presented preliminary results from the PRODIGY (PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY) trial. These results,